These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. N-terminal-pro-B-type natriuretic peptide (NT-proBNP): reference range for Chinese apparently healthy people and clinical performance in Chinese elderly patients with heart failure. Shi X; Xu G; Xia T; Song Y; Lin Q Clin Chim Acta; 2005 Oct; 360(1-2):122-7. PubMed ID: 16002063 [TBL] [Abstract][Full Text] [Related]
64. Diagnostic concordance between NT-proBNP and BNP for suspected heart failure. Farnsworth CW; Bailey AL; Jaffe AS; Scott MG Clin Biochem; 2018 Sep; 59():50-55. PubMed ID: 30111510 [TBL] [Abstract][Full Text] [Related]
65. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction. Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719 [TBL] [Abstract][Full Text] [Related]
66. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction. de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539 [TBL] [Abstract][Full Text] [Related]
67. The intracardiac concentrations of the N-terminal-pro B-type natriuretic peptide (NT-proBNP) and the determinants of its secretion in patients with atrial fibrillation. Streb W; Mitręga K; Szymała M; Woźniak A; Podolecki T; Kalarus Z Kardiol Pol; 2018; 76(2):433-439. PubMed ID: 29131295 [TBL] [Abstract][Full Text] [Related]
68. Usefulness of N-terminal-pro B-type natriuretic peptide as a heart failure marker in patients undergoing percutaneous left atrial appendage occlusion. Streb W; Mitręga K; Szymała M; Podolecki T; Kalarus Z Kardiol Pol; 2018; 76(1):166-172. PubMed ID: 28980292 [TBL] [Abstract][Full Text] [Related]
69. Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy. Gu L; Jiang W; Zheng R; Yao Y; Ma G Cardiology; 2021; 146(1):27-33. PubMed ID: 33264784 [TBL] [Abstract][Full Text] [Related]
70. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Januzzi JL; Chen-Tournoux AA; Moe G Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855 [TBL] [Abstract][Full Text] [Related]
71. Emergency thoracic ultrasound in the differentiation of the etiology of shortness of breath (ETUDES): sonographic B-lines and N-terminal pro-brain-type natriuretic peptide in diagnosing congestive heart failure. Liteplo AS; Marill KA; Villen T; Miller RM; Murray AF; Croft PE; Capp R; Noble VE Acad Emerg Med; 2009 Mar; 16(3):201-10. PubMed ID: 19183402 [TBL] [Abstract][Full Text] [Related]
72. Old markers, new approach to assessment of risk in heart failure. Kodziszewska K; Leszek P; Korewicki J; Piotrowski W Kardiol Pol; 2015; 73(6):387-95. PubMed ID: 25563469 [TBL] [Abstract][Full Text] [Related]
73. IVC diameter in patients with chronic heart failure: relationships and prognostic significance. Pellicori P; Carubelli V; Zhang J; Castiello T; Sherwi N; Clark AL; Cleland JG JACC Cardiovasc Imaging; 2013 Jan; 6(1):16-28. PubMed ID: 23328557 [TBL] [Abstract][Full Text] [Related]
74. The diagnostic value of serum and urinary NT-proBNP for heart failure. Michielsen EC; Bakker JA; Kimmenade RR; Pinto YM; Dieijen-Visser MP Ann Clin Biochem; 2008 Jul; 45(Pt 4):389-94. PubMed ID: 18583624 [TBL] [Abstract][Full Text] [Related]
75. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population]. El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022 [TBL] [Abstract][Full Text] [Related]
76. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction]. Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276 [No Abstract] [Full Text] [Related]
77. Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema. Behnes M; Lang S; Breithardt OA; Kaden JJ; Haghi D; Ahmad-Nejad P; Elmas E; Wolpert C; Borggrefe M; Neumaier M; Brueckmann M J Heart Valve Dis; 2008 Sep; 17(5):557-65. PubMed ID: 18980090 [TBL] [Abstract][Full Text] [Related]
78. Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP). Mueller T; Gegenhuber A; Poelz W; Haltmayer M Clin Chem Lab Med; 2004 Feb; 42(2):159-63. PubMed ID: 15061354 [TBL] [Abstract][Full Text] [Related]
79. MCL-1 (myosin light chains-1) in differential diagnosis of dyspnea. Stejskal D; Lacnák B; Andelová K; Skvarilová M; Bartek J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):89-91. PubMed ID: 16170394 [TBL] [Abstract][Full Text] [Related]
80. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure. Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]